RET and lung adenocarcinoma: RET point mutations were associated with medullary thyroid cancer (MTC)[6], whereas RET fusions were found in 20% of papillary thyroid carcinoma (PTC)[7] and 1%-2% of lung adenocarcinoma[8-11].